Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +



Aug. 22, 2016

Media Availability: Monkeys with Sudan ebolavirus Treated Successfully

Aug. 16, 2016

Media Availability: NIH Explores Connection Between Ebola Survival and Co-Infection with Malaria Parasites

July 5, 2016

PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA in Semen Opens in Liberia

April 29, 2016

Media Availability: Cancer Drug May Treat Sepsis, Other Uncontrollable Immune Responses to Infection

April 19, 2016

Media Availability: Two-Vaccine Ebola Regimen Shows Promise in Early-Stage Clinical Trial

April 4, 2016

Media Availability: NIH Doctors Describe Severe Case of Ebola Virus Disease

Feb. 25, 2016

Media Availability: Experimental Ebola Antibody Protects Monkeys

Feb. 23, 2016

Media Availability: Experimental Ebola Vaccines Well Tolerated, Immunogenic in Phase 2 Study

Feb. 23, 2016

Media Availability: Experimental Ebola Drug ZMapp May Benefit Patients, but Insufficient Data to be Certain, Study Finds

Feb.23, 2016

Media Availability: Ebola Survivor Study Yields Insights on Complications of Disease

Jan. 14, 2016

Media Availability: NIH Experts Offer Lessons Learned from the 2014-2015 Ebola Outbreak

Aug. 6, 2015

Media Availability: Single Dose Ebola Vaccine is Safe and Effective in Monkeys against Outbreak Strain

July 13, 2015

Media Availability: Investigational Aerosolized Ebola Vaccine Shows Promise in Nonhuman Primates

June 17, 2015

Study of Ebola Survivors Opens in Liberia

June 9, 2015

Media Availability: West African Ebola Virus Strain Less Virulent Than Prototype 1976 Strain

May 7, 2015

Statement: NIAID Recognizes Significant Milestone in Ebola Vaccine Study

April 1, 2015

Experimental Ebola Vaccine Safe, Prompts Immune Response

March 26, 2015

Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial

March 26, 2015

NIH Study Finds No Evidence of Accelerated Ebola Virus Evolution in West Africa

Feb. 27, 2015

Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments

Feb. 12, 2015

Media Availability: NIH Ebola Study in Macaques Provides Timeframes for Post-Mortem Viral Stability

Feb. 2, 2015

Ebola Vaccine Trial Opens in Liberia

Q&A: PREVAIL Phase 2/3 Clinical Trial of Investigational Ebola Vaccines

Dec. 23, 2014

Media Availability: Scientists Report on Trial of Early-Generation Ebola, Marburg Vaccine Candidates

Nov. 26, 2014

NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response

Nov. 26, 2014

Q & A: Phase 1 Clinical Trials of NIAID/GSK Investigational Ebola Vaccine

Oct. 22, 2014

NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine

Oct. 15, 2014

Media Availability: NIH Grants License Agreement for Candidate Ebola Vaccines

Sept. 7, 2014

Media Availability: Rapid and Durable Protection Against Ebola Virus With New Vaccine Regimens

Aug. 28, 2014

NIH to Launch Human Safety Study of Ebola Vaccine Candidate

Aug. 13, 2014

Media Availability: Ebola Outbreak Highlights Global Disparities in Healthcare Resources

May 7, 2014

Media Availability: Recent Ebola Outbreak Highlights Need for Better Global Response

Jan. 14, 2013

Media Availability: NIH Scientists Identify Protective Role for Antibodies in Ebola Vaccine Study

Last Updated August 22, 2016